1.Relationship among blood indicators of lipomobilization and hepatic function during early lactation in high-yielding dairy cows.
Felix Diaz GONZALEZ ; Rodrigo MUINO ; Victor PEREIRA ; Romulo CAMPOS ; Jose Luis BENEDITO
Journal of Veterinary Science 2011;12(3):251-255
Blood indicators are used as a tool to diagnose metabolic disorders. The present work was conducted to study the relationships among blood indicators of lipomobilization and hepatic function in high-yielding dairy cows. Two groups of Holstein cows were studied: 27 early lactation cows and 14 mid lactation cows from four different herds with similar husbandry characteristics in Galicia, Spain. Blood samples were obtained to measure beta-hydroxybutyrate (BHB), non-esterified fatty acids (NEFA), triglycerides (TG), and the activity of aspartate transaminase (AST) and gamma-glutamyl transferase. Cows in early lactation had higher levels of BHB and NEFA than mid lactation cows. High lipomobilization (NEFA > 400 micromol/L) was detected in 67% and 7% of early lactation and mid lactation cows, respectively, while subclinical ketosis (BHB > 1.2 mmol/L) was detected in 41% and 28% of the early lactation and lactation cows, respectively. TG concentrations were low in all cows suffering subclinical ketosis and in 61% of the cows with high lipomobilization. During early lactation, 30% of cows suffered hepatic lipidosis as detected by levels of AST. Compromised hepatic function was observed in early lactation cows as shown by lower concentrations of glucose, total protein, and urea.
3-Hydroxybutyric Acid/blood/diagnostic use
;
Animals
;
Aspartate Aminotransferases/blood/diagnostic use
;
Blood Glucose/analysis/metabolism
;
Blood Proteins/analysis/diagnostic use
;
Cattle
;
Cattle Diseases/blood/*diagnosis
;
Fatty Acids, Nonesterified/blood/diagnostic use
;
Female
;
Ketosis/blood/diagnosis/*veterinary
;
Lactation
;
*Lipid Mobilization
;
Lipidoses/blood/diagnosis/*veterinary
;
Liver Function Tests/veterinary
;
Spain
;
Triglycerides/blood/diagnostic use
;
Urea/blood/diagnostic use
;
gamma-Glutamyltransferase/blood/diagnostic use
2.Effect of Acid Pump Antagonist (Revaprazan, Revanex(R)) on Result of 13C Urea Breath Test in Patients with Helicobacter pylori Associated Peptic Ulcer Disease.
Ju Hyun OAK ; Woo Chul CHUNG ; Sung Hoon JUNG ; Kang Hyun CHOI ; Eun Jung KIM ; Bong Koo KANG ; Borami KANG ; Si Eun KONG ; Chang Nyol PAIK ; Kang Moon LEE
The Korean Journal of Gastroenterology 2011;57(1):8-13
BACKGROUND/AIMS: Revaprazan (Revanex(R)) is a novel proton pump inhibitor (PPI) that has a somewhat different effect on proton pump compared with the other PPI's, also (called as 'acid pump antagonist'). We aimed to examine the false negative rate of 13C-urea breath test (UBT) in the patients with Helicobacter pylori (H. pylori) associated peptic ulcer disease who were treated with revaprazan and evaluate the anti-urease activity of revaprazan. METHODS: Total 55 patients were enrolled in this study. They received EGD examination between January 2009 and December 2009 and diagnosed histologically as H. pylori associated peptic ulcer disease. All patients took revaprazan only. Three patients were excluded because of underlying chronic disease and inappropriate breath sampling. The remaining 52 patients had UBT at 0, 2 and 4 weeks of revaprazan use. After 2 weeks of the cessation of revaprazan, they had the fourth UBT. RESULTS: At 2 and 4 weeks, the false negative rates of UBT were 5.8% and 23.1%, respectively (p=0.05). After 2 weeks of the cessation, the cases of the false negative result were five. Four out of five patients had prolonged negative results on two or three successive tests, and baseline 13C difference value did not predict the false negative results. CONCLUSIONS: False negative results of UBT were common and increased with prolonged use of acid pump antagonist. As PPI, it had also anti-urease activity and most patients (47/52, 90.4%) reverted to positive results by 2 weeks after the cessation of taking the medication.
*Breath Tests
;
Carbon Isotopes
;
False Negative Reactions
;
Female
;
Helicobacter Infections/complications/*diagnosis
;
*Helicobacter pylori
;
Humans
;
Male
;
Middle Aged
;
Peptic Ulcer/*drug therapy/microbiology
;
Proton Pump Inhibitors/*therapeutic use
;
Pyrimidinones/*therapeutic use
;
Tetrahydroisoquinolines/*therapeutic use
;
Urea/*diagnostic use
3.Effect of Acid Pump Antagonist (Revaprazan, Revanex(R)) on the Result of 13C Urea Breath Test in the Patients with Helicobacter pylori Associated Peptic Ulcer Disease.
The Korean Journal of Gastroenterology 2011;57(1):1-2
No abstract available.
*Breath Tests
;
Carbon Isotopes
;
False Negative Reactions
;
Helicobacter Infections/complications/*diagnosis
;
*Helicobacter pylori
;
Humans
;
Peptic Ulcer/*drug therapy/microbiology
;
Proton Pump Inhibitors/*therapeutic use
;
Pyrimidinones/*therapeutic use
;
Tetrahydroisoquinolines/*therapeutic use
;
Urea/*diagnostic use